Placebo-controlled, Double Blind Study to Assess Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery (MMS).
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2014
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 18 Apr 2012 Planned initiation date changed from 1 Mar 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 10 Mar 2012 New trial record